India's Pharmaceutical Exports

Country Profile

Oman

Oman is a growing market for Indian pharmaceuticals — $60.2M in FY 2025–26, with 3.7× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $1.15M. The compound annual growth rate since FY2015 stands at 12.6%.

🇴🇲 $60.2M · 3.7× growth since FY2015 · 12.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$60.2M
Exports FY2025–26 DGCIS
3.7×
Growth FY2015→2026
12.6%
CAGR FY2015→2026
66%
Medicines Share
5
Product Categories Supplied
Oman is a growing market for Indian pharmaceuticals — $60.2M in FY 2025–26, with 3.7× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $1.15M. The compound annual growth rate since FY2015 stands at 12.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $39.8M (66.2%) Medicine Ingredients $14.7M (24.5%) Surgical & Hospital Supplies $3.02M (5.0%) Traditional & Herbal $1.42M (2.4%) Vaccines $1.15M (1.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Oman in the RBI overseas direct investment dataset (2011–2026).